The Medical and Endovascular Treatment of PAD: A Review of the Guidelines and Pivotal Clinical Trials

Mozaffarian, 2016, Heart disease and stroke statistics-2016 update: a Report From the American Heart Association, Circulation, 133, e38 Fowkes, 2013, Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis, Lancet, 382, 1329, 10.1016/S0140-6736(13)61249-0 Berger, 2013, Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories, J Vasc Surg, 58, 673, 10.1016/j.jvs.2013.01.053 Gerhard-Herman, 2017, 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, Circulation, 135, e726 Hirsch, 2001, Peripheral arterial disease detection, awareness, and treatment in primary care, JAMA, 286, 1317, 10.1001/jama.286.11.1317 McDermott, 2001, Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment, JAMA, 286, 1599, 10.1001/jama.286.13.1599 Fontaine, 1954, [Surgical treatment of peripheral circulation disorders], Helv Chir Acta, 21, 499 Rutherford, 1997, Recommended standards for reports dealing with lower extremity ischemia: revised version, J Vasc Surg, 26, 517, 10.1016/S0741-5214(97)70045-4 Wolfe, 1997, Critical and subcritical ischaemia, Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg, 13, 578, 10.1016/S1078-5884(97)80067-6 2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee, Lancet (London, England), 348, 1329, 10.1016/S0140-6736(96)09457-3 Cacoub, 2009, Patients with peripheral arterial disease in the CHARISMA trial, Eur Heart J, 30, 192, 10.1093/eurheartj/ehn534 Bhatt, 2007, Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial, J Am Coll Cardiol, 49, 1982, 10.1016/j.jacc.2007.03.025 Aung, 2007, Lipid-lowering for peripheral arterial disease of the lower limb, Cochrane Database Syst Rev, 10.1002/14651858.CD000123.pub2 2007, Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions, J Vasc Surg, 45, 645, 10.1016/j.jvs.2006.12.054 Kumbhani, 2014, Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry, Eur Heart J, 35, 2864, 10.1093/eurheartj/ehu080 Bavry, 2010, Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the international VErapamil-SR/Trandolapril study, Hypertension, 55, 48, 10.1161/HYPERTENSIONAHA.109.142240 Piller, 2014, Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT, J Gen Intern Med, 29, 147514, 10.1007/s11606-014-2947-1 Zanchetti, 2006, Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial, J Hypertens, 24, 2163, 10.1097/01.hjh.0000249692.96488.46 Diehm, 2011, Effect of nebivolol vs. hydrochlorothiazide on the walking capacity in hypertensive patients with intermittent claudication, J Hypertens, 29, 1448, 10.1097/HJH.0b013e3283471151 Espinola-Klein, 2011, beta-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial, Hypertension, 58, 148, 10.1161/HYPERTENSIONAHA.110.169169 Paravastu, 2013, Beta blockers for peripheral arterial disease, Cochrane Database Syst Rev, 10.1002/14651858.CD005508.pub3 Ostergren, 2004, Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease, Eur Heart J, 25, 17, 10.1016/j.ehj.2003.10.033 Yusuf, 2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients, N Engl J Med, 342, 145, 10.1056/NEJM200001203420301 Yusuf, 2008, Telmisartan, ramipril, or both in patients at high risk for vascular events, N Engl J Med, 358, 1547, 10.1056/NEJMoa0801317 Rogers, 2015, Clinical efficacy and safety of cilostazol: a critical review of the literature, Drugs, 75, 377, 10.1007/s40265-015-0364-3 Bedenis, 2014, Cilostazol for intermittent claudication, Cochrane Database Syst Rev, 10.1002/14651858.CD003748.pub4 Lee, 2014, Effect of cilostazol prescribed in a pragmatic treatment program for intermittent claudication, Vasc Endovasc Surg, 48, 224, 10.1177/1538574413518121 Leeper, 2013, Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes, PLoS One, 8, e63499, 10.1371/journal.pone.0063499 Salhiyyah, 2015, Pentoxifylline for intermittent claudication, Cochrane Database Syst Rev, 9 Dawson, 2000, A comparison of cilostazol and pentoxifylline for treating intermittent claudication, Am J Med, 109, 523, 10.1016/S0002-9343(00)00569-6 Davis, 2006, Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology, J Am Coll Cardiol, 48, 1498, 10.1016/j.jacc.2006.09.004 Gurfinkel, 2004, Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study, Eur Heart J, 25, 25, 10.1016/j.ehj.2003.10.018 Ciszewski, 2008, Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study, Eur Heart J, 29, 1350, 10.1093/eurheartj/ehm581 Bhatt, 2006, International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis, JAMA, 295, 180, 10.1001/jama.295.2.180 Hiatt, 1990, Benefit of exercise conditioning for patients with peripheral arterial disease, Circulation, 81, 602, 10.1161/01.CIR.81.2.602 Parmenter, 2015, Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis, Sports Med, 45, 231, 10.1007/s40279-014-0261-z Parmenter, 2015, Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis, Vasc Med, 20, 30, 10.1177/1358863X14559092 Pilz, 2014, Evaluation of 6- and 12-month supervised exercise training on strength and endurance parameters in patients with peripheral arterial disease, Wien Klin Wochenschr, 126, 383, 10.1007/s00508-014-0548-y Regensteiner, 1996, Exercise training improves functional status in patients with peripheral arterial disease, J Vasc Surg, 23, 104, 10.1016/S0741-5214(05)80040-0 Regensteiner, 1997, Exercise in the treatment of claudication: assessment and treatment of functional impairment, Vasc Med, 2, 238, 10.1177/1358863X9700200313 Stewart, 2002, Exercise training for claudication, N Engl J Med, 347, 1941, 10.1056/NEJMra021135 Fakhry, 2011, Long-term effects of structured home-based exercise program on functional capacity and quality of life in patients with intermittent claudication, Arch Phys Med Rehabil, 92, 1066, 10.1016/j.apmr.2011.02.007 Brenner, 2012, Exercise interventions for patients with peripheral arterial disease: a review of the literature, Physician Sportsmed, 40, 41, 10.3810/psm.2012.05.1964 Lane, 2017, Exercise for intermittent claudication, Cochrane Database Syst Rev, 12 Murphy, 2012, Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study, Circulation, 125, 130, 10.1161/CIRCULATIONAHA.111.075770 Murphy, 2015, Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study, J Am Coll Cardiol, 65, 999, 10.1016/j.jacc.2014.12.043 Fakhry, 2015, Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial, JAMA, 314, 1936, 10.1001/jama.2015.14851 Collins, 2011, Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease: a randomized controlled trial, Diabetes Care, 34, 2174, 10.2337/dc10-2399 Gardner, 2014, Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial, J Am Heart Assoc, 3, 10.1161/JAHA.114.001107 McDermott, 2012, The Group Oriented Arterial Leg Study (GOALS) to improve walking performance in patients with peripheral arterial disease, Contemp Clin Trials, 33, 1311, 10.1016/j.cct.2012.08.001 McDermott, 2013, Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial, JAMA, 310, 57, 10.1001/jama.2013.7231 Gardner, 2011, Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial, Circulation, 123, 491, 10.1161/CIRCULATIONAHA.110.963066 Mays, 2015, Community-based walking exercise for peripheral artery disease: an exploratory pilot study, Vasc Med, 20, 339, 10.1177/1358863X15572725 Treat-Jacobson, 2009, Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication, Vasc Med, 14, 203, 10.1177/1358863X08101858 Langbein, 2002, Increasing exercise tolerance of persons limited by claudication pain using polestriding, J Vasc Surg, 35, 887, 10.1067/mva.2002.123756 Walker, 2000, Influence of upper- and lower-limb exercise training on cardiovascular function and walking distances in patients with intermittent claudication, J Vasc Surg, 31, 662, 10.1067/mva.2000.104104 Bosanquet, 2014, Systematic review and meta-analysis of direct versus indirect angiosomal revascularisation of infrapopliteal arteries, Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg, 48, 88, 10.1016/j.ejvs.2014.04.002 Biancari, 2014, Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis, Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg, 47, 517, 10.1016/j.ejvs.2013.12.010 Jaff, 2015, Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv, 86, 611, 10.1002/ccd.26122 Olin, 2016, Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options, J Am Coll Cardiol, 67, 1338, 10.1016/j.jacc.2015.12.049 Jongkind, 2010, A systematic review of endovascular treatment of extensive aortoiliac occlusive disease, J Vasc Surg, 52, 1376, 10.1016/j.jvs.2010.04.080 Leville, 2006, Endovascular management of iliac artery occlusions: extending treatment to transatlantic inter-society consensus class C and D patients, J Vasc Surg, 43, 32, 10.1016/j.jvs.2005.09.034 Kashyap, 2008, The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction, J Vasc Surg, 48, 1451, 10.1016/j.jvs.2008.07.004 Henry, 1998, Percutaneous endoluminal treatment of iliac occlusions: long-term follow-up in 105 patients, J Cndovasc Surg Off J Int Soc Endovasc Surg, 5, 228 Kudo, 2005, Long-term outcomes and predictors of iliac angioplasty with selective stenting, J Vasc Surg, 42, 466, 10.1016/j.jvs.2005.05.002 Scheinert, 2001, Stent-supported recanalization of chronic iliac artery occlusions, Am J Med, 110, 708, 10.1016/S0002-9343(01)00727-6 de Donato, 2015, 24-Month Data from the BRAVISSIMO: a large-scale prospective registry on iliac stenting for TASC A & B and TASC C & D lesions, Ann Vasc Surg, 29, 738, 10.1016/j.avsg.2014.12.027 Mwipatayi, 2011, A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease, J Vasc Surg, 54, 1561, 10.1016/j.jvs.2011.06.097 Bekken, 2012, DISCOVER: Dutch Iliac Stent trial: COVERed balloon-expandable versus uncovered balloon-expandable stents in the common iliac artery: study protocol for a randomized controlled trial, Trials, 13, 215, 10.1186/1745-6215-13-215 Bonvini, 2011, Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures, J Am Coll Cardiol, 58, 792, 10.1016/j.jacc.2011.01.070 Paris, 2011, Catheter-based therapy of common femoral artery atherosclerotic disease, Vasc Med, 16, 109, 10.1177/1358863X11404280 Mehta, 2016, Percutaneous common femoral artery interventions using angioplasty, atherectomy, and stenting, J Vasc Surg, 64, 369, 10.1016/j.jvs.2016.03.418 Bonvini, 2013, Angioplasty and provisional stent treatment of common femoral artery lesions, J Vasc Interv Radiol, 24, 175, 10.1016/j.jvir.2012.10.020 Dattilo, 2013, Acute and medium-term outcomes of endovascular therapy of obstructive disease of diverse etiology of the common femoral artery, Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv, 81, 1013, 10.1002/ccd.24475 Goueffic, 2017, Stenting or Surgery for De Novo Common Femoral Artery Stenosis, JACC Cardiovasc Interv, 10, 1344, 10.1016/j.jcin.2017.03.046 Imran, 2018, Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease, Cardiovasc Revasc Med Stavroulakis, 2018, Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for common femoral artery atherosclerotic disease, J Endovasc Ther, 25, 92, 10.1177/1526602817748319 Shammas, 2016, Safety and Effectiveness of Closure Devices Applied to a Stented Common Femoral Artery: A Retrospective Analysis, Int J Angiol, 25, 165, 10.1055/s-0036-1572524 Early, 2011, The consequences of the mechanical environment of peripheral arteries for nitinol stenting, Med Biol Eng Comput, 49, 1279, 10.1007/s11517-011-0815-2 Rits, 2008, The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings, Eur J Vasc Endovasc Surg, 36, 339, 10.1016/j.ejvs.2008.05.005 Scheinert, 2005, Prevalence and clinical impact of stent fractures after femoropopliteal stenting, J Am Coll Cardiol, 45, 312, 10.1016/j.jacc.2004.11.026 Krankenberg, 2007, Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST), Circulation, 116, 285, 10.1161/CIRCULATIONAHA.107.689141 Schillinger, 2006, Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery, N Engl J Med, 354, 1879, 10.1056/NEJMoa051303 Dick, 2009, Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions, Catheter Cardiovasc Interv, 74, 1090, 10.1002/ccd.22128 Matsumi, 2016, Long-term outcomes of self-expandable nitinol stent implantation with intraluminal angioplasty to treat chronic total occlusion in the superficial femoral artery (transatlantic inter-society consensus type D lesions), J Invasive Cardiol, 28, 58 Dake, 2016, Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the zilver PTX randomized trial, Circulation, 133, 1472, 10.1161/CIRCULATIONAHA.115.016900 Schneider, 2018, Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial, Circ Cardiovasc Interv, 11, 10.1161/CIRCINTERVENTIONS.117.005891 Tepe, 2015, Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial, JACC Cardiovasc Interv, 8, 102, 10.1016/j.jcin.2014.07.023 Katsanos, 2016, Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability, J Endovasc Ther, 23, 356, 10.1177/1526602815626557 Katsanos, 2016, Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK, BMJ Open, 6, 10.1136/bmjopen-2016-011245 Jongsma, 2017, Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial, J Vasc Surg, 66, 1293, 10.1016/j.jvs.2017.05.098 Zeller, 2014, Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions, J Endovasc Ther, 21, 359, 10.1583/13-4630MR.1 Feldman, 2018, SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions, Catheter Cardiovasc Interv, 10.1002/ccd.27635 Schmidt, 2010, Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease, Catheter Cardiovasc Interv, 76, 1047, 10.1002/ccd.22658 Adam, 2005, Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial, Lancet, 366, 1925, 10.1016/S0140-6736(05)67704-5 Bradbury, 2010, Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy, J Vasc Surg, 51, 5s, 10.1016/j.jvs.2010.01.073 Soga, 2014, Two-year life expectancy in patients with critical limb ischemia, JACC Cardiovasc Interv, 7, 1444, 10.1016/j.jcin.2014.06.018 Farber, 2014, The BEST-CLI trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia, Tech Vasc Interv Radiol, 17, 221, 10.1053/j.tvir.2014.08.012 Bisdas, 2016, Endovascular Therapy versus bypass surgery as first-line treatment strategies for critical limb ischemia: results of the interim analysis of the CRITISCH registry, JACC Cardiovasc Interv, 9, 2557, 10.1016/j.jcin.2016.09.039 Iida, 2015, JACC Cardiovasc Interv, 8, 1493, 10.1016/j.jcin.2015.07.005 Liistro, 2013, Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia, Circulation, 128, 615, 10.1161/CIRCULATIONAHA.113.001811 Zeller, 2014, Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial, J Am Coll Cardiol, 64, 1568, 10.1016/j.jacc.2014.06.1198 Zeller, 2015, JACC Cardiovasc Interv, 8, 1614, 10.1016/j.jcin.2015.07.011 Scheinert, 2012, A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial, J Am Coll Cardiol, 60, 2290, 10.1016/j.jacc.2012.08.989 Katsanos, 2016, JACC Cardiovasc Interv, 9, 259, 10.1016/j.jcin.2015.10.038 Bosiers, 2012, Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease, J Vasc Surg, 55, 390, 10.1016/j.jvs.2011.07.099 Rastan, 2011, Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial, Eur Heart J, 32, 2274, 10.1093/eurheartj/ehr144 Rastan, 2012, Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial, J Am Coll Cardiol, 60, 587, 10.1016/j.jacc.2012.04.035 Siablis, 2014, Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial, JACC Cardiovasc Interv, 7, 1048, 10.1016/j.jcin.2014.04.015